Greenspring Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Greenspring Advisors's AMGN Position: Q2 2026 in Review
Greenspring Advisors increased its Amgen (AMGN) stake by 0.12% in Q2 2026, buying an estimated $2.74K and bringing the position to 6,730 shares worth $2.44M. The position accounts for 0.14% of the portfolio, ranked #84.
Greenspring Advisors first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Greenspring Advisors held 6,730 shares of Amgen worth $2.44M as of Q2 2026.
- Greenspring Advisors bought 8 Amgen shares in Q2 2026, an estimated $2.74K.
- Amgen made up 0.14% of Greenspring Advisors's portfolio in Q2 2026, its #84 holding.
- Greenspring Advisors first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Greenspring Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.